Designed for faculty and staff engaged in clinical care delivery or its management Johns Hopkins recognizes that a learning health system mindset is central to…
Older people may be at greater risk of developing pancreatic cancer and have poorer prognoses because of age-related changes in cells in the pancreas called…
A novel three-drug combination achieved notable responses in patients with advanced HER2-negative breast cancer, according to new research directed by investigators from the Johns Hopkins Kimmel…
The Research Navigators regularly receive questions covering a wide range of topics about conducting research studies at Johns Hopkins. It is not uncommon for multiple…
Researchers used genetic markers in maternal blood that serve as “stand-ins” for brain molecules Researchers in a Johns Hopkins Children’s Center-led study that used genetic…
This article discusses the work of Jacky Jennings, PhD, MPH, BIRCWH Award program mentor. Across the United States, a growing number of families with low…
A combination of two cancer drugs could be effective against malignant peripheral nerve sheath tumors (MPNSTs) — soft tissue tumors that are stubbornly resistant to…
Johns Hopkins neuroscientists show how specialized cells signal the presence of light simultaneously in two distinct ways Working with mammalian retinal cells, neuroscientists at Johns…
Letter of Intent Deadline: Friday, February 9, 2024 Application Deadline: Friday, March 1, 2024 The Fisher Center for Environmental Infectious Diseases, through the continued…
Credit: Adobe Stock Soy compounds called isoflavones are among the plant-derived compounds that may significantly reduce the risk of breast cancer recurrence or death,…
